Filtered By:
Vaccination: Hepatitis Vaccine

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 4921 results found since Jan 2013.

Infectious diseases and cognition: do we have to worry?
CONCLUSIONS: Taken together, the studies examined in the present review emphasize that numerous acute and chronic infectious diseases share mechanisms that, when added to specific risk factors frequently found in older persons, contribute to considerably increase the risk of cognitive outcomes such as cognitive decline and dementia. This review may help to appreciate the role that infectious diseases play in cognitive trajectories and thus promote further investigation on the topic.PMID:35867217 | DOI:10.1007/s10072-022-06280-9
Source: Herpes - July 22, 2022 Category: Infectious Diseases Authors: Virgilio Hernandez-Ruiz Luc Letenneur Tamas F ülöp Catherine Helmer Claire Roubaud-Baudron Jos é-Alberto Avila-Funes H élène Amieva Source Type: research

Stem cells as an ideal carrier for gene therapy: A new approach to the treatment of hepatitis C virus
CONCLUSION: Gene therapy, either directly and in vivo or indirectly and in vitro, requires carriers (vectors) to transfer the gene. These carriers are divided into two groups, viral and non-viral. In indirect gene therapy, living cells are isolated from a person's body and genetically modified. Stem cells have the properties to transfer the desired genes to the patient's body, including the ability to proliferate for a long time and differentiate into the tissue cells in which they are located.PMID:36150664 | DOI:10.1016/j.trim.2022.101721
Source: Transplant Immunology - September 23, 2022 Category: Transplant Surgery Authors: Alireza Rafati Hadi Esmaeili Gouvarchin Ghaleh Afsaneh Azarabadi Mahmood Reza Masoudi Elmira Afrasiab Akbar Ghorbani Alvanegh Source Type: research

The current and future burden of hepatitis B in Switzerland: a modelling study
CONCLUSIONS: Thanks to the historical vaccination programmes and the continued rollout of universal 3-dose coverage in the first year of life, Switzerland is expected to exceed the global health sector strategy targets for the reduction of incidence. While overall prevalence is decreasing, the current diagnosis and treatment levels remain below global health sector strategy targets.PMID:37410921 | DOI:10.57187/smw.2023.40086
Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Francesco Negro Beat M üllhaupt David Semela Sarah Blach Philip Bruggmann Andrea De Gottardi Jean-Francois Dufour Montserrat Fraga Antonio Galante Homie Razavi Joana Vieira Barbosa Devin Razavi-Shearer Source Type: research

Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6
Obstet Gynecol. 2023 Sep 1;142(3):745-759. doi: 10.1097/AOG.0000000000005300.ABSTRACTPURPOSE: The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION: Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS: This guideline was developed using an a ...
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Source Type: research

Small-molecule Inhibitors for the Treatment of Hepatitis B Virus Documented in Patents.
Abstract Hepatitis B virus (HBV) infection is a serious health problem worldwide, and the current treatment methods including vaccines, immunomodulators, interferons and nucleoside analogs are far from satisfactory. For the search of new anti-HBV agents, much investigation has revealed a large number of small-molecule compounds with various skeletons and promising anti-HBV activities. Although some reviews on anti-HBV progress have been published, they are mainly concentrated on the results reported in journal articles. This review provides an overview of the structural features and anti-HBV properties of the smal...
Source: Mini Reviews in Medicinal Chemistry - January 10, 2013 Category: Chemistry Authors: Geng CA, Wang LJ, Guo RH, Chen JJ Tags: Mini Rev Med Chem Source Type: research